JP2003506462A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003506462A5 JP2003506462A5 JP2001515895A JP2001515895A JP2003506462A5 JP 2003506462 A5 JP2003506462 A5 JP 2003506462A5 JP 2001515895 A JP2001515895 A JP 2001515895A JP 2001515895 A JP2001515895 A JP 2001515895A JP 2003506462 A5 JP2003506462 A5 JP 2003506462A5
- Authority
- JP
- Japan
- Prior art keywords
- weight
- pharmaceutical composition
- diol
- composition according
- laurocapram
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 description 16
- 239000008194 pharmaceutical composition Substances 0.000 description 16
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 10
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 10
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 10
- 238000000034 method Methods 0.000 description 8
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 description 7
- 239000013543 active substance Substances 0.000 description 7
- 150000002009 diols Chemical class 0.000 description 7
- 229960003639 laurocapram Drugs 0.000 description 7
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 6
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 6
- 229960000541 cetyl alcohol Drugs 0.000 description 5
- 229940075507 glyceryl monostearate Drugs 0.000 description 5
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 5
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 230000002757 inflammatory effect Effects 0.000 description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- 206010012442 Dermatitis contact Diseases 0.000 description 2
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 description 2
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 description 2
- 208000010247 contact dermatitis Diseases 0.000 description 2
- 239000003246 corticosteroid Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000479 mixture part Substances 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 239000012049 topical pharmaceutical composition Substances 0.000 description 1
- YNDXUCZADRHECN-JNQJZLCISA-N triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 description 1
- 229960002117 triamcinolone acetonide Drugs 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14075699P | 1999-06-25 | 1999-06-25 | |
| US60/140,756 | 1999-06-25 | ||
| PCT/US1999/022313 WO2001000139A1 (en) | 1999-06-25 | 1999-09-28 | Topical formulations comprising skin penetration agents and the use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003506462A JP2003506462A (ja) | 2003-02-18 |
| JP2003506462A5 true JP2003506462A5 (https=) | 2006-11-24 |
Family
ID=22492675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001515895A Pending JP2003506462A (ja) | 1999-06-25 | 1999-09-28 | 皮膚浸透剤を含む局所処方物およびその使用 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6271219B2 (https=) |
| EP (1) | EP1194109B1 (https=) |
| JP (1) | JP2003506462A (https=) |
| KR (1) | KR100623534B1 (https=) |
| AT (1) | ATE273682T1 (https=) |
| AU (1) | AU769079B2 (https=) |
| BR (1) | BR9917389B1 (https=) |
| CA (1) | CA2376850C (https=) |
| DE (1) | DE69919597T2 (https=) |
| DK (1) | DK1194109T3 (https=) |
| ES (1) | ES2224755T3 (https=) |
| MX (1) | MXPA01013460A (https=) |
| NZ (1) | NZ516765A (https=) |
| PT (1) | PT1194109E (https=) |
| WO (1) | WO2001000139A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006057616A1 (en) * | 2004-11-29 | 2006-06-01 | Ambria Dermatology Ab | A composition comprising at least 3 different diols |
| IL142535A0 (en) * | 2001-04-11 | 2002-03-10 | Yeda Res & Dev | Pharmaceutical compositions for the treatment of inflammation |
| US8987263B2 (en) | 2002-10-10 | 2015-03-24 | Meir Shinitzky | Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agents |
| US20050101605A1 (en) * | 2003-11-07 | 2005-05-12 | Ahmed Salah U. | Oral liquid formulations of methotrexate |
| EP2114155A4 (en) | 2007-02-26 | 2014-04-16 | Yeda Res & Dev | AMINO-PHENYL-ACETIC ACID OCTADEC-9- (Z) ENANTIOMERS, THEIR SALTS AND USES THEREOF |
| KR100987121B1 (ko) * | 2010-08-12 | 2010-10-12 | 연세대학교 산학협력단 | 창문닦기로봇 |
| US8809307B2 (en) | 2010-11-22 | 2014-08-19 | Dow Pharmaceutical Sciences, Inc. | Pharmaceutical formulations containing corticosteroids for topical administration |
| US11957753B2 (en) | 2010-11-22 | 2024-04-16 | Bausch Health Ireland Limited | Pharmaceutical formulations containing corticosteroids for topical administration |
| US8853189B2 (en) | 2012-05-31 | 2014-10-07 | Prima Innovations, Llc | Antispasmodic 1,2-Diols and 1,2,3-triols |
| HK1223300A1 (zh) * | 2013-06-03 | 2017-07-28 | Tolmar, Inc. | 皮质类固醇组合物 |
| CN104161721A (zh) * | 2014-07-14 | 2014-11-26 | 湖北博康医药科技有限公司 | 一种用于治疗皮肤病的蛇王药剂及其制备方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4316893A (en) | 1975-06-19 | 1982-02-23 | Nelson Research & Development Co. | Vehicle composition containing 1-substituted azacycloalkan-2-ones |
| BE843140A (fr) | 1975-06-19 | 1976-10-18 | Aazacycloalcan-2-ones 1-substituees et compositions pharmaceutiques contenant ces composes a titre d'excipients | |
| US4444762A (en) | 1980-04-04 | 1984-04-24 | Nelson Research & Development Company | Vehicle composition containing 1-substituted azacyclopentan-2-ones |
| US4552872A (en) | 1983-06-21 | 1985-11-12 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing corticosteroids |
| US4557934A (en) | 1983-06-21 | 1985-12-10 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one |
| US4537776A (en) | 1983-06-21 | 1985-08-27 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone |
| US4886783A (en) | 1986-01-31 | 1989-12-12 | Nelson Research & Development Co. | Penetration enhancers for transdermal delivery of systemic agents |
| US5196410A (en) * | 1986-10-31 | 1993-03-23 | Pfizer Inc. | Transdermal flux enhancing compositions |
| US4863970A (en) * | 1986-11-14 | 1989-09-05 | Theratech, Inc. | Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols |
| JPH0676328B2 (ja) * | 1987-04-14 | 1994-09-28 | 株式会社大塚製薬工場 | ステロイドクリ−ム製剤 |
| DK0437225T3 (da) * | 1990-01-10 | 1994-06-27 | Hoffmann La Roche | Topiske præparater |
| JP3207212B2 (ja) * | 1991-03-01 | 2001-09-10 | 久光製薬株式会社 | 吸収促進剤およびこれを含有する外用剤 |
| US5607691A (en) * | 1992-06-12 | 1997-03-04 | Affymax Technologies N.V. | Compositions and methods for enhanced drug delivery |
| JPH06219947A (ja) * | 1993-01-26 | 1994-08-09 | Kinki Univ | 経皮投与製剤 |
| US5601839A (en) | 1995-04-26 | 1997-02-11 | Theratech, Inc. | Triacetin as a penetration enhancer for transdermal delivery of a basic drug |
| EP0942697A1 (en) * | 1996-10-30 | 1999-09-22 | THERATECH, INC. (a Delaware Corporation) | Fatty acid esters of lactic acid salts as permeation enhancers |
-
1999
- 1999-09-28 BR BRPI9917389-1A patent/BR9917389B1/pt not_active IP Right Cessation
- 1999-09-28 AT AT99973935T patent/ATE273682T1/de active
- 1999-09-28 WO PCT/US1999/022313 patent/WO2001000139A1/en not_active Ceased
- 1999-09-28 NZ NZ516765A patent/NZ516765A/xx not_active IP Right Cessation
- 1999-09-28 CA CA002376850A patent/CA2376850C/en not_active Expired - Fee Related
- 1999-09-28 PT PT99973935T patent/PT1194109E/pt unknown
- 1999-09-28 AU AU60607/99A patent/AU769079B2/en not_active Ceased
- 1999-09-28 KR KR1020017016610A patent/KR100623534B1/ko not_active Expired - Fee Related
- 1999-09-28 DK DK99973935T patent/DK1194109T3/da active
- 1999-09-28 EP EP99973935A patent/EP1194109B1/en not_active Expired - Lifetime
- 1999-09-28 ES ES99973935T patent/ES2224755T3/es not_active Expired - Lifetime
- 1999-09-28 MX MXPA01013460A patent/MXPA01013460A/es active IP Right Grant
- 1999-09-28 DE DE69919597T patent/DE69919597T2/de not_active Expired - Lifetime
- 1999-09-28 US US09/406,918 patent/US6271219B2/en not_active Expired - Lifetime
- 1999-09-28 JP JP2001515895A patent/JP2003506462A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7622218B2 (ja) | 円形脱毛症治療用の複方外用製剤及びその製造方法 | |
| JP6473134B2 (ja) | フルニソリドの局所用組成物および治療方法 | |
| JP2003506462A5 (https=) | ||
| JPH0643317B2 (ja) | 抗炎症クリーム組成物 | |
| JPH042570B2 (https=) | ||
| JPH0131485B2 (https=) | ||
| EP3435973A1 (en) | Apremilast pharmaceutical compositions | |
| JPH0729929B2 (ja) | ハイドロコ−チゾンジエステルを含有するクリ−ム | |
| WO2021234362A1 (en) | Topical disulfiram for treating viral infections | |
| CA2376850A1 (en) | Topical formulations comprising skin penetration agents and the use thereof | |
| JPH042571B2 (https=) | ||
| JP5307309B2 (ja) | 吉草酸酢酸プレドニゾロン及び塩基性局所麻酔薬を配合した外用剤 | |
| KR19990044454A (ko) | 지속성 직장 투여용 조성물 | |
| JP3420540B2 (ja) | 坐剤用基剤及び坐剤 | |
| WO1999001137A1 (en) | Azelastine hydrochloride-containing percutaneous preparation having good percutaneous absorbability and reduced skin irritation | |
| CZ868686A3 (en) | Primicin-containing colloidal elementary gel, and process for preparing thereof | |
| JPS6341474A (ja) | 抗炎症剤 | |
| US4602040A (en) | Meclofenamic acid topical pharmaceutical composition | |
| JP3031990B2 (ja) | 消炎鎮痛クリーム剤組成物 | |
| JPH0735332B2 (ja) | 外用クリ−ム製剤 | |
| EP0119852A1 (en) | Podophyllotoxin preparations for use in the treatment of genital warts | |
| JP5890939B2 (ja) | 鎮痙性１，２−ジオール及び１，２，３−トリオール | |
| JP3470131B2 (ja) | 持効性点鼻剤 | |
| EP3876905A1 (en) | Teriflunomide topical pharmaceutical compositions | |
| JP7601398B2 (ja) | てんかん治療用又は自閉症スペクトラム障害治療用外用剤 |